Profound Medical Corp (PROF) Cumulative Dividend Pay out History TTM by Quarter, Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
• Dividend Growth
• Cumulative Pay out
Profound Medical Corp   (NASDAQ: PROF)

 

PROF's Dividend Pay out ratio over the 12 Months Period

Cumulative by Quarter, Trailing twelve months

Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.



According to the latest data Mar 31 2026, it is not possible to calculate dividend pay out ratio.
Visit Profound Medical Corp Cash flow


Dividend in Glossary



Back to PROF Dividend Comparisons >> See also PROF's dividend growth by quarter >> See also PROF's eps growth
Cumulative Dividend Pay out Ratio I. Quarter
(Mar 31 2026)		 IV. Quarter
(Dec 31 2025)		 III. Quarter
(Sep 30 2025)		 II. Quarter
(Jun 30 2025)		 I. Quarter
(Mar 31 2025)
PROF's Pay out Ratio (TTM) - - - - -
PROF's Dividend Pay out Ratio Total Ranking # # # # #

  News about Profound Medical Corp Dividends

Sophisticated Profound Medical Achieves Spectacular Revenue Milestones and Secures $40 Million Offering: A Pioneering Force in Oncology Innovation,

Profound Medical Reports Strong Revenue Growth for Q4 and Full Year 2024 Amidst Ongoing Innovations in OncologyProfound Medical, a leading entity in the field of medical technology focusing on the treatment of prostate cancer, has recently released preliminary unaudited revenues for the fourth quarter and the full year of 2024. This announcement highlights a remarkable year for the company, with estimated revenue growth projected between 105% to 110% year-over-year in the fourth quarter. As of the latest updates, this performance underscores the success of Profound Medical's unique offering, which lies at the confluence of advanced technology and effective cancer treatment methods.The significant revenue increase signals an expanding market adoption of the company’s innovative treatment solutions, primarily its TULSA-PRO system. This technology leverages real-time MRI-guided transurethral ultrasound to provide minimally invasive treatment options for prostate cancer patients. As the healthcare sector increasingly shifts towards personalized and less invasive treatment modalities, Profound Medical appears to be riding the wave of this transformation. The projected growth not only reflects robust market demand but also signifies increased confidence among healthcare providers in the efficacy and safety of Profound’s solutions.

PROF's Dividend Pay out Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
S&P 500 #

Dividend Pay out Ratio Statistics
High Average Low
0 % 0 % 0 %
 



Other Dividend Ratios
Highest Ranking Dividend Yield
Lowest Ranking Dividend Yield
Annual Dividend Pay out for PROF
PROF's Dividend Yield




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.